Helen Louise Collins
CHIEF MEDICAL OFFICER; Director · 9 filings · Latest: Jun 17, 2026
Enliven Therapeutics, Inc.
Kura Oncology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | Collins Helen Louise | — | Oct 18, 2024 | Proposed Sale | $28.02 | 25,000 | $700.5K | — |
← Previous
Page 2 of 2